Detailed information for compound 1695470

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 465.604 | Formula: C27H31NO4S
  • H donors: 1 H acceptors: 3 LogP: 5.52 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 1
  • SMILES: OC(=O)CCCCCOc1cccc(c1)CN(C(=O)c1ccc(cc1)c1cscc1)C(C)C
  • InChi: 1S/C27H31NO4S/c1-20(2)28(27(31)23-12-10-22(11-13-23)24-14-16-33-19-24)18-21-7-6-8-25(17-21)32-15-5-3-4-9-26(29)30/h6-8,10-14,16-17,19-20H,3-5,9,15,18H2,1-2H3,(H,29,30)
  • InChiKey: JHEQGSNNOKXHNZ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium vivax diacylglycerol O-acyltransferase, putative 0.00641127 0.11359 0.5
Loa Loa (eye worm) potassium voltage-gated channel subfamily Q member 5 0.0136012 0.381147 0.388524
Plasmodium falciparum diacylglycerol O-acyltransferase 0.00641127 0.11359 0.5
Toxoplasma gondii acyl-CoA:diacylglycerol acyltransferase 1-related enzyme 0.00641127 0.11359 0.5
Loa Loa (eye worm) hypothetical protein 0.0136012 0.381147 0.388524
Loa Loa (eye worm) diacylglycerol acyltransferase 0.00641127 0.11359 0.115789
Loa Loa (eye worm) hypothetical protein 0.00531474 0.0727853 0.0741941
Echinococcus multilocularis potassium voltage gated channel subfamily KQT 0.0302314 1 1
Echinococcus multilocularis potassium voltage gated channel subfamily KQT 0.0136012 0.381147 0.327403
Echinococcus multilocularis diacylglycerol O acyltransferase 1 0.00641127 0.11359 0.0366106
Echinococcus granulosus potassium channel KvQLT family member kqt 1 0.0302314 1 1
Brugia malayi Voltage-gated potassium channel, KCNQ (Kv7-like) alpha-subunit. C. elegans kqt-1 ortholog 0.0302314 1 1
Onchocerca volvulus Matrix metalloproteinase homolog 0.00335881 0 0.5
Loa Loa (eye worm) voltage-gated potassium channel 0.0297212 0.981013 1
Echinococcus granulosus potassium voltage gated channel subfamily KQT 0.0136012 0.381147 0.327403
Schistosoma mansoni voltage-gated potassium channel KCNQ 0.0302314 1 1
Toxoplasma gondii acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha 0.00641127 0.11359 0.5
Loa Loa (eye worm) matrixin family protein 0.00366163 0.0112686 0.0114867
Brugia malayi diacylglycerol acyltransferase 0.00641127 0.11359 0.103488
Echinococcus granulosus diacylglycerol O acyltransferase 1 0.00641127 0.11359 0.0366106
Loa Loa (eye worm) hypothetical protein 0.0136012 0.381147 0.388524
Onchocerca volvulus Matrilysin homolog 0.00335881 0 0.5

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) > 15.015 uM Antimalarial activity against chloroquine-resistant Plasmodium falciparum 3D7 incubated for 72 hrs by DNA staining based MARK1 growth inhibition assay ChEMBL. 22727641
EC50 (ADMET) > 26.0417 uM Cytotoxicity against human HepG2 cells after 72 hrs by resazurin dye based CellTiterGlo reagent assay ChEMBL. 22727641

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23 22727641

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.